Propofol protects rat astroglial cells against tert-butyl hydroperoxide-induced cytotoxicity; the effect on histone and cAMP-response-element-binding protein (CREB) signalling

Journal of Physiology and Pharmacology

Volumn 60, Issue 4, 2009, Pages 63-69

  Holownia, Adam ^a   Mroz, R M ^a   Wielgat, P ^a   Skiepko, A ^a   Sitko, E ^a   Jakubow, P ^a   Kolodziejczyk, A ^a   Braszko, J J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Astroglia; cAMP response element binding protein; Histone acetylation; Oxidative stress; Propofol

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ENOLASE; GLUTAMATE AMMONIA LIGASE; HISTONE; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; PROPOFOL; TERT BUTYL HYDROPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASTROCYTE; CELL COUNT; CELL GROWTH; CELL SURVIVAL; CHROMATIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; INFLAMMATION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ANESTHETICS, INTRAVENOUS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; CHROMATIN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GLUTAMATE-AMMONIA LIGASE; HISTONE ACETYLTRANSFERASES; HISTONES; OXIDATIVE STRESS; PHOSPHOPYRUVATE HYDRATASE; PHOSPHORYLATION; PROPOFOL; PROTEIN TRANSPORT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TERT-BUTYLHYDROPEROXIDE;

EID: 75749098511     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wong C, Burry L, Molino-Carmona S, et al. Analgesic and sedative pharmacology in the intensive care unit. Dynamics 2004; 15: 23-26.
2. Trapani G, Altomare C, Liso G, Sanna E, Biggio G . Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem 2000; 7: 249-271.
3. Feng CS, Ma HC, Yue Y, Zhang YQ, Qu XD. Effect of propofol on the activation of nuclear factor-kappa B and expression of inflammatory cytokines in cerebral cortex during transient focal cerebral ischemia-reperfusion: experiment with rats. Zhonghua Yi Xue Za Zhi 2004; 84: 2110-2114.
4. Sanchez-Conde P, Rodriguez-Lopez JM, Nicolas JL, et al. The comparative abilities of propofol and sevoflurane to modulate inflammation and oxidative stress in the kidney after aortic cross-clamping. Anesth Analg 2008; 106: 371-378.
5. Nakahata K, Kinoshita H, Azma T, et al. Propofol restores brain microvascular function impaired by high glucose via the decrease in oxidative stress. Anesthesiology 2008; 108: 269-275.
6. Liu KX, Rinne T, He W, Wang F, Xia Z. Propofol attenuates intestinal mucosa injury induced by intestinal ischemiareperfusion in the rat. Can J Anaesth 2007; 54: 366-374.
7. Runzer TD, Ansley DM, Godin DV, Chambers GK. Tissue antioxidant capacity during anesthesia: propofol enhances in vivo red cell and tissue antioxidant capacity in a rat model. Anesth Analg 2002; 94: 89-93.
8. De La Cruz JP, Zanca A, Carmona, JA, de la Cuesta FS. The effect of propofol on oxidative stress in platelets from surgical patients. Anesth Analg 1999; 89: 1050-1055.
9. Peters CE, Korcok J, Gelb AW, Wilson JX. Anesthetic concentrations of propofol protect against oxidative stress in primary astrocyte cultures: comparison with hypothermia. Anesthesiology 2001; 94: 313-321.
10. Boland A, Delapierre D, Mossay D, Hans P, Dresse A. Propofol protects cultured brain cells from iron ioninduced death: comparison with trolox. Eur J Pharmacol 2000; 404: 21-27.
11. Iwata-Ichikawa E, Kondo Y, Miyazaki I., Asanuma M, Ogawa N. Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis. J Neurochem 1999; 72: 2334-2344.
12. Dringen R, Pfeiffer B, Hamprecht B. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 1999; 19: 562-569.
13. Morasca L, Erba E. Flow Cytometry. In Animal Cell Culture, A Practical Approach. RI Freshney (ed). IRL Press, Oxford UK, 1986, pp. 142-143.
14. Kornblatt MJ, Zheng SX, Lamande N, Lazar M. Cloning, expression and mutagenesis of a subunit contact of rabbit muscle-specific (ββ) enolase. Biochim Biophys Acta 2002; 1597: 311-319.
15. Reinhardt CA, Schein CH. Glutamine synthetase activity as a marker of toxicity in cultures of embryonic chick brain and retina cells. Toxicol in Vitro 1995; 9: 369-374.
16. Ostrovidov S, Franck P, Joseph D, Martarello L, Kirsch G, Belleville F, et al. Screening of new antioxidant molecules using flow cytometry. J Med Chem 2000; 43: 1762-1769.
17. Lecoeur H, Prevost MC, Gougeon ML. Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V/propidium iodide assay. Cytometry 2001; 44: 65-72.
18. Chadee DN, Hendzel MJ, Tylipski CP, et al. Increased ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene - transformed mouse fibroblasts. J Biol Chem 1999; 274: 24914-24920.
19. Santini V, Gozzini A, Ferrari G. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr Drug Metabol 2007; 8: 383-93.
20. Li Volti G, Murabito P, Attaguile G, Rodella LF. Antioxidant properties of propofol; when oxidative stress sleeps with patients. EXCLI J 2006; 5: 25-32.
21. Lao N, Nie H, Xu LX, et al. Efficacy of intracarotid propofol infusion and impact of cerebral blood flow alteration. Br J Anaesth 2009; 102: 234-239.
22. Vasileiou I, Xanthos T, Koudouna E, et al. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol 2009; 605: 1-8.
23. Reynolds A, Laurie C, Mosley RL, Gendelman HE. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 2007; 82: 297-325.
24. Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Brit J Anaesth 2007; 99: 4-9.
25. Acquaviva R, Campisi A, Murabito P, et al. Propofol attenuates peroxynitrite-mediated DNA damage and apoptosis in cultured astrocytes: an alternative protective mechanism. Anesthesiology 2004; 101: 1363-1371.
26. Acquaviva R, Campisi A., Raciti G, et al. Propofol inhibits caspase-3 in astroglial cells: role of heme oxygenase-1. Curr Neurovasc Res 2005; 2: 141-148.
27. 2+ homeostasis in human astrocytoma cells. Brain Res 2007; 1145: 11-18.
28. Daskalopoulos R, Korcok J, Tao L, Wilson JX. Accumulation of intracellular ascorbate from dehydroascorbic acid by astrocytes is decreased after oxidative stress and restored by propofol. Glia 2002; 39: 124-132.
29. Lowes DA, Galley HF, Lowe PR, Rikke BA, Johnson TE, Webster NR. A microarray analysis of potential genes underlying the neurosensitivity of mice to propofol. Anesth Analg 2005; 101: 697-704.
30. Mroz RM, Holownia A, Chyczewska E, Braszko JJ. Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment. J Physiol Pharmacol 2008; 59: 35-42.
31. Mroz RM, Noparlik J, Chyczewska E, Braszko JJ, Holownia A. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. J Physiol Pharmacol 2007; 58: 453-446.
32. Storck S, Shukla M, Dimitrov S, Bouvet P. Functions of the histone chaperone nucleolin in diseases. Subcell Biochem 2007; 41: 125-144.
33. Shandilya J, Gadad S, Swaminathan V, Kundu TK. Histone chaperones in chromatin dynamics: implications in disease manifestation. Subcell Biochem 2007; 41: 111-124.
34. Choudhary P, Varga-Weisz P. ATP-dependent chromatin remodelling: action and reaction Subcell Biochem 2007; 41: 29-43.
35. Kozinn J, Mao L, Arora A, Yang L, Fibuch EE, Wang JQ. Inhibition of glutamatergic activation of extracellular signalregulated protein kinases in hippocampal neurons by the intravenous anesthetic propofol. Anesthesiology 2006; 105: 1182-1191.
36. Jin K, Mao XO, Simon RP, Greenberg DA. Cyclic AMP response element binding protein (CREB) and CREB binding protein (CBP) in global cerebral ischemia. J Mol Neurosci 2001; 16: 49-56.
37. Holownia A, Mroz RM, Noparlik J, Chyczewska E, Braszko JJ. Expression of CREB-binding protein and peroxisome proliferator-activated receptor gamma during formoterol or formoterol and corticosteroid therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol 2008; 59: 303-309.
38. Mroz RM, Holownia A, Chyczewska E, et al. Cytoplasmnuclear trafficking of CREB and CREB phosphorylation at Ser133 during therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol 2007; 58: 437-444.
39. Kitagawa K. CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J 2007; 274: 3210-3217.
40. Chang YC, Huang CC. Perinatal brain injury and regulation of transcription. Curr Opin Neurol 2006; 19: 141-147.
41. Kaltschmidt B, Ndiaye D, Korte M, et al. NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling. Mol Cell Biol 2006; 26: 2936-2946.
42. Berthiaume M, Boufaied N, Moisan A, Gaudreau L. High levels of oxidative stress globally inhibit gene transcription and histone acetylation. DNA Cell Biol 2006; 25: 124-134.
43. Adcock IM, Ito K, Barnes PJ. Histone deacetylation: an important mechanism in inflammatory lung diseases. COPD 2005; 2: 445-455.
44. Yun JY, Park KS, Kim JH, Do SH, Zuo Z. Propofol reverses oxidative stress-attenuated glutamate transporter EAAT3 activity: evidence of protein kinase C involvement. Eur J Pharmacol 2007; 565: 83-88.